Astrana Health (NASDAQ:ASTH) Price Target Raised to $70.00 at BTIG Research
Astrana Health (NASDAQ:ASTH – Free Report) had its target price boosted by BTIG Research from $60.00 to $70.00 in a research report released on Thursday morning, Benzinga reports. BTIG Research currently has a buy rating on the stock. Other equities analysts have also issued research reports about the company. Stifel Nicolaus raised their target price […]
7 Oct 07:51 · The Markets Daily